Ittai Ben Porath, The Hebrew University of Jerusalem
Arkaitz Carracedo. CIC bioGUNE
Rony Dahan, Weizmann Institute of Science
John Dick, Princess Margaret Cancer Centre, University Health Network
Ayelet Erez, Weizmann Institute of Science
Neta Erez, Tel Aviv University
Peter Friedl, Radboud University Medical Center
Tom Gajewski, The University of Chicago
Naama Geva-Zatorsky, Technion- Israel Institute of Technology
Eyal Gottlieb,Technion-Israel Institute of Technology
Mary Claire King, University of Washington
Valery Krizhanovsky, Weizmann Institute of Science
Sima Lev, Weizmann Institute of Science
Scott Lowe, Geoffrey Beene Cancer Research Center Sloan Kettering Institute
David Malkin, University of Toronto
George Miller, Trinity Health of New England
Sergio A. Quezada, University College London
Gidi Rechavi, The Chaim Sheba Medical Center
Varda Rotter, Weizmann Institute of Science
Yardena Samuels, Weizmann Institute of Science
Ronit Satchi-Fainaro, Tel Aviv University
Avigdor Scherz, Weizmann Institute of Science
Ruth Scherz-Shouval, Weizmann Institute of Science
Avi Schroeder, Technion – Israel Institute of Technology
Yuval Shaked, Technion – Israel Institute of Technology
Ravid Straussman, Weizmann Institute of Science
Itay Tirosh, Weizmann Institute of Science
Andreas Trumpp, Deutsches Krebsforschungszentrum Im Neuenheimer
David Tuveson, Cancer Center Cold Spring Harbor Laboratory
Jennifer Wargo, The University of Texas
Valerie Weaver, University of California
Jedd Wolchok, Parker Institute for Cancer Immunotherapy